Mosaic ImmunoEngineering Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mosaic ImmunoEngineering Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Mosaic ImmunoEngineering Inc. Return On Equity for the quarter ending September 30, 2024 was 17 %, a 28.6% decline year-over-year.
  • Mosaic ImmunoEngineering Inc. annual Return On Equity for 2023 was 18.4 %, a 67.4% decline from 2022.
  • Mosaic ImmunoEngineering Inc. annual Return On Equity for 2022 was 56.3 %, a 71.5% decline from 2021.
  • Mosaic ImmunoEngineering Inc. annual Return On Equity for 2021 was 197 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 17 -6.79 -28.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 20.1 -1.45 -6.72% Apr 1, 2024 Jun 30, 2024
Q1 2024 15.7 -27.3 -63.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 18.4 -37.9 -67.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 23.8 -49 -67.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 21.6 -91.7 -80.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 43 -104 -70.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 56.3 -141 -71.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 72.7 -199 -73.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 113 -273 -70.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 147 -378 -72.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 197 -1.17K -85.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 272 +935 Jul 1, 2021 Sep 30, 2021
Q2 2021 386 +628 Apr 1, 2021 Jun 30, 2021
Q1 2021 525 +556 Jan 1, 2021 Mar 31, 2021
Q4 2020 1.37K +1.46K Sep 1, 2020 Nov 30, 2020
Q3 2020 -663 -611 -1171% Jul 1, 2020 Sep 30, 2020
Q2 2020 -242* -202 Apr 1, 2020 Jun 30, 2020
Q1 2020 -31 +7.76 +20% Mar 30, 2020 Mar 31, 2020
Q4 2019 -88.4 -50.1 -131% Sep 1, 2019 Nov 30, 2019
Q3 2019 -52.1 -9.68 -22.8% Jun 1, 2019 Aug 31, 2019
Q2 2019 -39.7 +1.44 +3.5% Mar 1, 2019 May 31, 2019
Q1 2019 -38.8 -0.96 -2.54% Dec 1, 2018 Feb 28, 2019
Q4 2018 -38.3 -2.29 -6.35% Sep 1, 2018 Nov 30, 2018
Q3 2018 -42.5 -43.4 -4469% Jun 1, 2018 Aug 31, 2018
Q2 2018 -41.1 -39.9 -3399% Mar 1, 2018 May 31, 2018
Q1 2018 -37.8 -30.3 -403% Dec 1, 2017 Feb 28, 2018
Q4 2017 -36.1 -23 -177% Sep 1, 2017 Nov 30, 2017
Q3 2017 0.97 +39.4 Jun 1, 2017 Aug 31, 2017
Q2 2017 -1.17 +27.2 +95.9% Mar 1, 2017 May 31, 2017
Q1 2017 -7.51 +18.2 +70.7% Dec 1, 2016 Feb 28, 2017
Q4 2016 -13 +0.21 +1.59% Sep 1, 2016 Nov 30, 2016
Q3 2016 -38.5 -19 -97.6% Jun 1, 2016 Aug 31, 2016
Q2 2016 -28.4 -0.29 -1.03% Mar 1, 2016 May 31, 2016
Q1 2016 -25.7 +2.57 +9.1% Dec 1, 2015 Feb 29, 2016
Q4 2015 -13.2 +19.7 +59.9% Sep 1, 2015 Nov 30, 2015
Q3 2015 -19.5 +3.46 +15.1% Jun 1, 2015 Aug 31, 2015
Q2 2015 -28.1 -8.01 -39.9% Mar 1, 2015 May 31, 2015
Q1 2015 -28.3 -39.8 -345% Dec 1, 2014 Feb 28, 2015
Q4 2014 -32.9 -37.9 -756% Sep 1, 2014 Nov 30, 2014
Q3 2014 -22.9 -43.2 -213% Jun 1, 2014 Aug 31, 2014
Q2 2014 -20.1 -35.7 -228% Mar 1, 2014 May 31, 2014
Q1 2014 11.6 +42.9 Dec 1, 2013 Feb 28, 2014
Q4 2013 5.02 +38.6 Sep 1, 2013 Nov 30, 2013
Q3 2013 20.3 +78.8 Jun 1, 2013 Aug 31, 2013
Q2 2013 15.6 +68.4 Mar 1, 2013 May 31, 2013
Q1 2013 -31.3 +23.5 +42.9% Dec 1, 2012 Feb 28, 2013
Q4 2012 -33.5 Sep 1, 2012 Nov 30, 2012
Q3 2012 -58.5 Jun 1, 2012 Aug 31, 2012
Q2 2012 -52.8 Mar 1, 2012 May 31, 2012
Q1 2012 -54.8 Dec 1, 2011 Feb 29, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.